Non Vascular Stents Market By Product Type, Material Type, Application, & Region for 2026-2032

Non Vascular Stents Market Valuation - 2026-2032

The prevalence of chronic diseases requiring stenting procedures, such as biliary, gastrointestinal, and urological disorders, is increasing. As populations age, the prevalence of these conditions increases, necessitating a greater need for effective treatment options such as non-vascular stenting. Technological advancements have also played an important role in the development of innovative stent designs, such as biodegradable and drug-eluting stents, which improve patient outcomes while lowering the risk of complications such as restenosis and migration driving the market growth surpassing USD 1.21 Billion in 2024 and reaching USD 1.71 Billion by 2032.

Furthermore, the growing preference for minimally invasive procedures has accelerated the use of non-vascular stents, which are associated with shorter recovery times and lower risks than traditional surgical methods. Together, these factors are driving demand for non-vascular stents, positioning the market for further growth is expected to grow at a CAGR of about 4.80% from 2026 to 2032.

Non Vascular Stents Market: Definition/ Overview

Non-vascular stents are medical devices that open or unblock ducts and passageways in non-vascular organs such as the bile ducts, ureters, esophagus, and intestines. Their primary use is to treat conditions such as obstructions, strictures, and tumors that obstruct the natural flow of these organs, providing an important solution in gastrointestinal, urological, and respiratory medicine. The future of non-vascular stents looks promising, thanks to advances in stent materials and designs like biodegradable and drug-eluting stents, which are expected to improve patient outcomes, reduce complications, and expand their use in broader clinical applications. As the prevalence of chronic diseases continues to rise, the demand for these minimally invasive treatments will grow, making non-vascular stents an increasingly vital component of modern healthcare.

Will Increasing Prevalence of Chronic Diseases Drive the Non Vascular Stents Market?

The rising incidence of chronic diseases is a major driver of the non-vascular stents market. Chronic conditions such as biliary, gastrointestinal, and urological disorders frequently necessitate stenting procedures to keep ducts and passageways open. As these diseases become more common, particularly in older populations, the demand for non-vascular stents is expected to rise. For example, the increasing prevalence of biliary diseases, such as bile duct obstruction caused by gallstones or tumours, necessitates the use of biliary stents to relieve blockages and improve patient outcomes.

In October 2024, Boston Scientific announced the introduction of a new fully covered metal stent for the treatment of benign biliary strictures, reflecting ongoing innovation aimed at improving stent performance and patient safety. Such technological advancements not only improve the efficacy of stents, but also broaden their application to a variety of chronic conditions, driving market growth.

In June 2024, the FDA approved a new drug-eluting esophageal stent, providing a novel treatment option for patients with esophageal cancer. This approval demonstrates the growing regulatory support for advanced stent technologies, which is expected to spur additional research and development in the field. As governments and healthcare organizations continue to prioritize the treatment of chronic diseases, the non-vascular stents market is expected to grow steadily in the coming years.

Will Rising Risk of Complications of Infection Hamper the Non Vascular Stents Market?

The rising risk of complications, particularly infections, is a major concern that may impede the growth of the non-vascular stents market. Infections associated with stent placement are a serious concern because they can have serious consequences for patients, such as longer hospital stays, additional surgeries, and higher healthcare costs. The fear of such complications may deter both physicians and patients from choosing stent-based treatments, limiting the market's potential growth.

Furthermore, the risk of infection can have an impact on the reputation and use of non-vascular stents. Healthcare providers may be more cautious about recommending stent procedures if infection risks are increased, particularly in vulnerable patient populations. This cautious approach may slow the adoption of new stent technologies, despite advancements in design and materials to reduce infection risks.

In addition to these direct consequences, the increased risk of complications such as infection may lead to stricter regulatory requirements for the approval of new stent products. This could increase the time and cost of bringing new stents to market, stifling market growth. As a result, manufacturers may face difficulties in developing and marketing innovative stents that can mitigate these risks while remaining cost-effective and accessible to a wide range of patients.

Category-Wise Acumens

Will Rising Demand of Gastrointestinal Stents Propel the Non Vascular Stents Market?

The increasing demand for gastrointestinal stents is expected to significantly boost the non-vascular stents market. Gastrointestinal stents are critical for managing a variety of conditions, including esophageal strictures, gastrointestinal obstructions, and tumors, all of which are becoming more common as the population ages and chronic diseases such as cancer become more prevalent. The growing demand for effective solutions in these areas is resulting in the dominance of gastrointestinal stents, driving market growth.

In March 2024, Medtronic announced the release of an advanced esophageal stent, with the goal of improving patient outcomes through increased durability. This development reflects ongoing innovation aimed at improving the efficacy and safety of gastrointestinal stents in response to rising demand caused by complex medical conditions. Such innovations not only broaden the market, but also increase the popularity of gastrointestinal stents in clinical practice.

For instance, in July 2024, the US FDA granted expedited approval for a new biodegradable stent intended for use in the GI tract. This regulatory endorsement emphasizes the commitment to improving treatment options for gastrointestinal disorders and encourages wider use of stents. As healthcare policies prioritize advanced treatment technologies, the non-vascular stents market is expected to expand further, driven by rising demand for gastrointestinal stents.

However, the urological stents segment is expected to grow at the fastest rate. This expansion is fueled by the rising prevalence of urological disorders such as kidney stones and benign prostatic hyperplasia (BPH). The rising prevalence of these conditions, combined with advances in stent technology that improve patient outcomes and reduce complications, is driving the rapid growth of the urological stents market.

Will Rising Usage of Metal Stents Drive the Non Vascular Stents Market?

The increasing use of metal stents is expected to fuel significant growth in the non-vascular stents market. Metal stents, which are known for their durability and structural integrity, are used to treat a variety of non-vascular conditions, including biliary obstructions and esophageal strictures. Their ability to provide long-term support and keep ducts and passageways open has made them a popular choice among clinicians, resulting in increased demand and market expansion.

In August 2024, the European Medicines Agency (EMA) approved a new generation of metal stents with advanced features for gastrointestinal use. This regulatory approval demonstrates the industry's commitment to improving stent technology and encouraging wider adoption. As regulatory bodies continue to support innovative solutions and address clinical needs, the non-vascular stents market is expected to benefit from increased use of metal stents, owing to their proven efficacy and technological advancements.

Biodegradable stents are the fastest growing segment. This rapid growth is driven by their innovative design, which overcomes the limitations of traditional stents by gradually dissolving in the body, lowering the risk of long-term complications and the need for additional procedures. The growing emphasis on patient safety and the demand for minimally invasive solutions are driving the adoption of biodegradable stents, making them a key market growth opportunity.

Country/Region-wise

Will Increasing Advanced Healthcare Infrastructure in North America Drive the Non Vascular Stents Market?

The expanding advanced healthcare infrastructure in North America is expected to drive significant growth in the non-vascular stents market. The region's robust healthcare system, which includes cutting-edge medical facilities, comprehensive patient care, and high levels of healthcare spending, encourages the widespread use of advanced medical technologies, such as non-vascular stents. Enhanced infrastructure enables the integration of cutting-edge stent technologies and gives patients access to sophisticated treatments that improve outcomes for a variety of non-vascular conditions.

Furthermore, industry advancements help to drive growth. In July 2024, Medtronic unveiled its new series of non-vascular stents, with research and development supported by the region's advanced healthcare infrastructure. This release emphasizes the importance of sophisticated healthcare environments in the development and distribution of medical technologies. As North America continues to dominate owing to investment and expanding healthcare capabilities, the non-vascular stents market is expected to grow, owing to increased access to and use of advanced medical devices.

Will Rising Awareness of Advanced Treatment Options in Asia-Pacific Propel the Non Vascular Stents Market?

Rising awareness of advanced treatment options in Asia-Pacific is expected to enable the region witness rapid growth in the non-vascular stents market. As the region's healthcare systems evolve and improve, more patients and providers are becoming aware of the advantages and accessibility of advanced medical devices such as non-vascular stents. This increased awareness is driving increased adoption of these devices, as more people seek cutting-edge treatments for conditions like gastrointestinal obstructions, urological issues, and pulmonary disorders.

In March 2024, the Indian Ministry of Health launched a national campaign to educate healthcare professionals and the public about advanced treatment technologies, such as non-vascular stents. This initiative is part of a larger effort to improve healthcare outcomes and give patients access to the most recent medical innovations. Such campaigns are critical for closing the knowledge gap and encouraging the use of advanced treatment options throughout the region.

In April 2024, Olympus Corporation introduced a new line of non-vascular stents designed specifically for the Asia-Pacific market, with innovative designs that address regional healthcare needs. This move reflects the growing demand for sophisticated medical solutions, which is driven by increased awareness and access to healthcare. As education and technology advance, the non-vascular stents market in Asia-Pacific is expected to expand significantly, driven by increased patient awareness and improved healthcare infrastructure.

Competitive Landscape

The competitive landscape of the non-vascular stents market is characterized by a mix of established companies and emerging players focusing on innovation and expanding their product portfolios. Companies are investing in R&D to develop stents with improved materials, flexibility, and biocompatibility to meet the specific needs of various non-vascular applications, such as biliary, esophageal, and ureteral stenting. Additionally, strategic partnerships, acquisitions, and regional expansions are common strategies as companies aim to enhance their market presence and reach. The market is also witnessing an increase in the adoption of minimally invasive procedures, further driving competition among manufacturers.

Some of the prominent players operating in the non vascular stents market include:

Becton

Dickinson and Company (BD)

Boston Scientific Corporation

CONMED Corporation

Cook Medical

ELLA-CS s.r.o.

Medtronic

Micro-Tech (Nanjing) Co. Ltd.

Merit Medical Systems

Latest Developments

In June 2024, The FDA approved their latest biliary stent, which has increased flexibility and anti-migration properties. This new product aims to increase patient comfort while reducing the need for repeat procedures.

In May 2024, Cook Medical introduced a new line of esophageal stents designed for easier placement and less tissue irritation. The stents are expected to gain popularity in treating both malignant and benign esophageal strictures.

In August 2024, Merit Medical Systems announced the acquisition of a smaller stent manufacturer, which will broaden their portfolio of gastroenterology products and increase their non-vascular stent market share.

In September 2024, Taewoong Medical has signed a distribution agreement with a major European medical device company to expand the reach of their non-vascular stents throughout Europe, with a focus on the esophageal and biliary stent markets.

Non Vascular Stents Market, By Category

• Product Type:
• Gastrointestinal Stents
• Urological Stents
• Pulmonary Stents
• Biliary Stents
• Pancreatic Stents
• Material Type:
• Metal Stents
• Plastic/Polymer Stents
• Biodegradable Stents
• Hybrid Stents
• Application:
• Gastrointestinal Disorders
• Urological Disorders
• Pulmonary Disorders
• Biliary Disorders
• Pancreatic Disorders
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa